Charles River Labs on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley rated Charles River Laboratories International, Inc. at hold on news of the company's stronger-than-expected third-quarter results. The company reported non-GAAP earnings per share of $0.56 on $264.7 million in revenue, compared with the analyst's estimate of $0.52 on $264.8 million and consensus of $0.54 on $263.9 million. Shares of the Wilmington, Mass.-based pharmaceutical products company were up $1.46, or 3.43%, at $44.06. (NYSE: CRL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.